Agents affecting the digestive system and metabolism
| Name | Dosage form | ATC code |
|---|---|---|
  Alpha-tocopherol acetate (vitamin E) Oral oil solution Active ingredient
Group of action Agents affecting the digestive system and metabolism |
50 mg/ml, 20 ml № 1 | A11HA03 |
 Alpha-tocopherol acetate (vitamin E) Oral oil solution Active ingredient
Group of action Agents affecting the digestive system and metabolism |
100 mg/ml, 20 ml № 1 | A11HA03 |
 Alpha-tocopherol acetate (vitamin E) Oral oil solution Active ingredient
Group of action Agents affecting the digestive system and metabolism |
300 mg/ml, 20 ml № 1 | A11HA03 |
  Aquavit-D3 Oral solution Active ingredient
Group of action Agents affecting the digestive system and metabolism |
375 mcg/ml, 10 ml № 1 | A11CC05 |
  Ascorbic acid Solution for injections Active ingredient
Group of action Agents affecting the digestive system and metabolism |
50 mg/ml, 2 ml № 10, № 100 | A11GA01 |
 Ascorbic acid Solution for injections Active ingredient
Group of action Agents affecting the digestive system and metabolism |
100 mg/ml, 2 ml № 10, № 100 | A11GA01 |
  Ascorbic acid Tablets Active ingredient
Group of action Agents affecting the digestive system and metabolism |
25 mg № 50, № 100 | A11GA01 |
  Ascorbic acid Dragee Active ingredient
Group of action Agents affecting the digestive system and metabolism |
50 mg № 50 | A11GA01 |
  Bisacodyl Rectal suppositories Active ingredient
Group of action Agents affecting the digestive system and metabolism |
0,01 g № 10 | A06AB02 |
 Carbacid Pechaevskiy Chewable tablets Active ingredient
Group of action Agents affecting the digestive system and metabolism |
№ 20 | A02AX |
 Dalmaxin Suppositories Active ingredient
Group of action Agents affecting the digestive system and metabolism |
0,2 g № 5, № 10 | A05BA |
 Ergocalciferol (vitamin D2) Oral oil solution Active ingredient
Group of action Agents affecting the digestive system and metabolism |
0,125 %, 10 ml № 1 | A11CC01 |
 Glibenclamide Tablets Active ingredient
Group of action Agents affecting the digestive system and metabolism |
5 mg № 30 | А10ВВ01 |
 Hexavit Dragee Active ingredient
Group of action Agents affecting the digestive system and metabolism |
№ 50 | A11BA |
  Kreazim 10000 Hard capsules Active ingredient
Group of action Agents affecting the digestive system and metabolism |
№ 20 | A09AA02 |
 Kreazim 20000 Hard capsules Active ingredient
Group of action Agents affecting the digestive system and metabolism |
№ 20 | A09AA02 |
 Lactulose Syrup Active ingredient
Group of action Agents affecting the digestive system and metabolism |
670 mg/ml, 100 ml, 200 ml № 1 | A06AD11 |
|
|
2 ml № 5 | А11DВ |
 Leksadyl  Active ingredient
Group of action Agents affecting the digestive system and metabolism |
10 mg № 10 | А06АВ02 |
|
|
150 mg № 10, № 20, № 30 | A02BA02 |
 Loperamide Tablets Active ingredient
Group of action Agents affecting the digestive system and metabolism |
0,002 g № 10, № 20 | A07DA03 |
 |
1 vial and 1 ampoule | А02ВС01 |
 Methovitan Hard capsules Active ingredient
Group of action Agents affecting the digestive system and metabolism |
20 hard capsules | А11АВ |
 Methyluracil Rectal suppositories Active ingredient
Group of action Agents affecting the digestive system and metabolism |
0,5 g, № 5 ,№ 10 | A14B |
 Nevrolek Solution for injections Active ingredient
Group of action Agents affecting the digestive system and metabolism |
2 ml № 5 | A11DB |
 No-H-Sha Tablets Active ingredient
Group of action Agents affecting the digestive system and metabolism |
0,04 g № 10, № 30 | A03A D02 |
 No-H-Sha Solution for injections Active ingredient
Group of action Agents affecting the digestive system and metabolism |
20 mg/mg, 2 ml in ampoules № 5 | A03AD02 |
 No-H-Sha Rectal suppositories Active ingredient
Group of action Agents affecting the digestive system and metabolism |
0,04 g № 5 | A03AD02 |
 No-H-Sha forte Tablets Active ingredient
Group of action Agents affecting the digestive system and metabolism |
0,08 g № 30 | A03AD02 |
 Ondansetron Film-coated tablets Active ingredient
Group of action Agents affecting the digestive system and metabolism |
8 mg № 10 | A04AA01 |
 Ondansetron Solution for injections Active ingredient
Group of action Agents affecting the digestive system and metabolism |
2 mg/ml, 2 ml or 4 ml № 5 | A04AA01 |
 Ondansetron Film-coated tablets Active ingredient
Group of action Agents affecting the digestive system and metabolism |
4 mg № 10 | A04AA01 |
 Pancreatin 8000 Enterosoluble tablets Active ingredient
Group of action Agents affecting the digestive system and metabolism |
№ 20, №50 | A09AA02 |
 Pancreazim Enterosoluble tablets Active ingredient
Group of action Agents affecting the digestive system and metabolism |
№ 20, № 50 | A09AA02 |
 Pancreazim 10000 Enterosoluble tablets Active ingredient
Group of action Agents affecting the digestive system and metabolism |
№ 20, № 50 | А09АА02 |
 Pancreazim 10000 Active ingredient
Group of action Agents affecting the digestive system and metabolism |
№ 20, № 50 | А09АА02 |
 Papaverine Solution for injections Active ingredient
Group of action Agents affecting the digestive system and metabolism |
20 mg/ml, 2 ml № 10 | A03AD01 |
 Peridon Tablets Active ingredient
Group of action Agents affecting the digestive system and metabolism |
0,01 g, № 10, № 30 | A03FA03 |
 Pyridoxine hydrochloride (vitamin В6) Solution for injections Active ingredient
Group of action Agents affecting the digestive system and metabolism |
50 mg/ml, 1 ml № 10 | A11HA02 |
 Ranitidine Film-coated tablets Active ingredient
Group of action Agents affecting the digestive system and metabolism |
150 mg № 10, № 20, № 30 | A02BA02 |
 Renalgani Solution for injections Active ingredient
Group of action Agents affecting the digestive system and metabolism |
2 ml or 5 ml № 5, № 10 | A03DA02 |
 Renalgani Tablets Active ingredient
Group of action Agents affecting the digestive system and metabolism |
№ 10, № 20 | A03DA02 |
 Retinol Acetate (vitamin A) Oral oil solution Active ingredient
Group of action Agents affecting the digestive system and metabolism |
34,4 mg/ml, 10 ml № 1 | A11CA01 |
 Revit Dragee Active ingredient
Group of action Agents affecting the digestive system and metabolism |
№ 75, № 100 | A11BA |
 Sea buckthorn oil Suppositories Active ingredient
Group of action Agents affecting the digestive system and metabolism |
0,35 g №10 | A16AX10 |
 Solizym forte Enterosoluble tablets Active ingredient
Group of action Agents affecting the digestive system and metabolism |
№ 20 | A09AA |
  Stomolik Solution for oral cavity Active ingredient
Group of action Agents affecting the digestive system and metabolism |
125 ml № 1 | А01АВ12 |
 Thiamine chloride (vitamin В1) Solution for injections Active ingredient
Group of action Agents affecting the digestive system and metabolism |
50 mg/ml, 1 ml in ampoules № 10 | A11DA01 |
 Undevit Dragee Active ingredient
Group of action Agents affecting the digestive system and metabolism |
№ 50 | A11BA |
Agents affecting blood system and hemapoiesis
| Name | Dosage form | ATC code |
|---|---|---|
 Aquaferrol Syrup Active ingredient
Group of action Agents affecting blood system and hemapoiesis |
10 mg/ml, 125 ml № 1 | В03АВ05 |
 Cyanocobalamin (vitamin В12) Solution for injections Active ingredient
Group of action Agents affecting blood system and hemapoiesis |
0,5 mg/ml, 1 ml № 10 | B03BA01 |
  Ferrofol Chewable tablets Active ingredient
Group of action Agents affecting blood system and hemapoiesis |
№ 30 | В03АD04 |
 Folic acid Tablets Active ingredient
Group of action Agents affecting blood system and hemapoiesis |
5 mg № 50 | B03BB01 |
 Folic acid Tablets Active ingredient
Group of action Agents affecting blood system and hemapoiesis |
1 mg № 50 | B03BB01 |
 Magnesium sulfate Solution for injections Active ingredient
Group of action Agents affecting blood system and hemapoiesis |
50 mg/ml, 5 ml № 10 | B05XA05 |
 Sodium chloride Solution for injections Active ingredient
Group of action Agents affecting blood system and hemapoiesis |
9 mg/ml, 5 ml №10 | B05XA03 |
 Tranexamic acid Solution for injections Active ingredient
Group of action Agents affecting blood system and hemapoiesis |
50 mg/ml, 5 ml № 5, № 10, № 100 | B02AA02 |
 Tranexamic acid Solution for injections Active ingredient
Group of action Agents affecting blood system and hemapoiesis |
100 mg/ml, 5 ml № 5, № 10, № 100 | B02AA02 |
 Trombolik-Cardio Enterosoluble tablets Active ingredient
Group of action Agents affecting blood system and hemapoiesis |
100 mg № 20 | B01AC06 |
Agents affecting cardio-vascular system
| Name | Dosage form | ATC code |
|---|---|---|
 Accordin Solution for injections Active ingredient
Group of action Agents affecting cardio-vascular system |
100 mg/ml, 5 ml № 5, № 10, № 100 | С01ЕВ22 |
 Amiodarone Tablets Active ingredient
Group of action Agents affecting cardio-vascular system |
0,2 g № 30 | C01BD01 |
 Amlodipine Tablets Active ingredient
Group of action Agents affecting cardio-vascular system |
5 mg № 30, № 60, № 90, № 1000 | C08CA01 |
 Amlodipine Tablets Active ingredient
Group of action Agents affecting cardio-vascular system |
10 mg № 30, № 60, № 90, № 900 | C08CA01 |
 Anestezol Suppositories Active ingredient
Group of action Agents affecting cardio-vascular system |
№ 5, № 10 | C05AD |
 Ascorutin Tablets Active ingredient
Group of action Agents affecting cardio-vascular system |
№ 50, № 800 | C05CA51 |
 Beladonna Rectal suppositories Active ingredient
Group of action Agents affecting cardio-vascular system |
0,015 g № 10 | C05AX |
 Bendazol Solution for injections Active ingredient
Group of action Agents affecting cardio-vascular system |
10 mg/ml, 1 ml, 5 ml № 5, № 10, № 100 | С04АХ |
 Betiol Rectal suppositories Active ingredient
Group of action Agents affecting cardio-vascular system |
№ 10 | C05AX03 |
 Carductal Film-coated tablets Active ingredient
Group of action Agents affecting cardio-vascular system |
20 mg № 30, № 60 | C01EB15 |
 Corargin Film-coated tablets Active ingredient
Group of action Agents affecting cardio-vascular system |
№ 50 | C01EX |
 Enalapril Tablets Active ingredient
Group of action Agents affecting cardio-vascular system |
0,01 g № 10, № 20, № 30, № 50, № 90 | C09AA02 |
|
|
15 mg № 10 | C05AX |
|
|
№ 5, № 10 | C05AD |
 Nicotinic acid Tablets Active ingredient
Group of action Agents affecting cardio-vascular system |
50 mg № 50 | C04AC01 |
 Nifedipine Film-coated tablets Active ingredient
Group of action Agents affecting cardio-vascular system |
20 mg № 50 | C08CA05 |
 Nifedipine Film-coated tablets Active ingredient
Group of action Agents affecting cardio-vascular system |
10 mg № 50 | C08CA05 |
 Nitroglycerin Sublingual tablets Active ingredient
Group of action Agents affecting cardio-vascular system |
0,5 mg № 40 | C01DA02 |
 Nitrogranulong Prolonged release tablets Active ingredient
Group of action Agents affecting cardio-vascular system |
5,2 mg № 10, № 50 | C01DA02 |
 Nitrogranulong Prolonged release tablets Active ingredient
Group of action Agents affecting cardio-vascular system |
2,9 mg № 10, № 50 | C01DA02 |
 Oftalek Solution for injections Active ingredient
Group of action Agents affecting cardio-vascular system |
10 mg/ml 1 ml №10 | С05СX |
 Pentoxifylline Enterosoluble tablets Active ingredient
Group of action Agents affecting cardio-vascular system |
100 mg № 10, № 50 | C04AD03 |
 Proctozol Rectal suppositories Active ingredient
Group of action Agents affecting cardio-vascular system |
№ 5, № 10 | C05AD51 |
 Propolis Suppositories Active ingredient
Group of action Agents affecting cardio-vascular system |
0,1 g № 5, № 10 | C05AX |
 Riboxin Film-coated tablets Active ingredient
Group of action Agents affecting cardio-vascular system |
200 mg № 10, № 50 | C01EB |
 Torasemide Solution for injections Active ingredient
Group of action Agents affecting cardio-vascular system |
5 mg/ml 2 ml, 4 ml № 5, № 10, № 100 | C03CA04 |
 Validol Pechaevskiy sugarfree Tablets Active ingredient
Group of action Agents affecting cardio-vascular system |
60 mg № 10 | C01EX |
 Validol-Natur Pechaevskiy Sublingual tablets Active ingredient
Group of action Agents affecting cardio-vascular system |
№ 10 | C01EX |
Dermatological agents
| Name | Dosage form | ATC code |
|---|---|---|
|
|
50 ml, 100 ml № 1 | D03AX |
|
|
50 ml, 100 ml | D03АX |
 Iodine Pechaevskiy Solution for external administration Active ingredient
Group of action Dermatological agents |
10 %, 30 ml, 120 ml, 1000 ml № 1 | D08AG02 |
 |
10 ml № 1 | D01AE22 |
Agents affecting genitourinary system and reproductive hormones
| Name | Dosage form | ATC code |
|---|---|---|
 Evkolek Suppositories Active ingredient
|
0,05 g № 5, № 10 | G01AX |
 Hinofucin Vaginal suppositories Active ingredient
|
0,015 g № 5, № 10 | G01AC03 |
 Klioron Vaginal suppositories Active ingredient
|
16 mg № 10 | G01AX |
 Klioron V |
16 mg № 10 | G01AX |
 Lekfucin Active ingredient
|
15 mg № 5, № 10 | G01AС03 |
 Leknazole Active ingredient
|
150 mg № 3 | G01АF05 |
 Levoklek Active ingredient
|
50 mg № 5, № 10 | G01AX |
 Omix Hard capsules Active ingredient
|
0,4 mg № 10, № 30 | G04CA02 |
 Potentiale Film-coated tablets Active ingredient
|
100 mg № 1, № 2, №4 | G04BE03 |
 Potentiale Film-coated tablets Active ingredient
|
50 mg № 1, № 2, № 4 | G04BE03 |
 Povidin Vaginal suppositories Active ingredient
|
0,3 g № 5, № 10 | G01AX11 |
 Prostan Film-coated tablets Active ingredient
|
5 mg № 10, № 30 | G04CB01 |
 Prostatilen Rectal suppositories Active ingredient
|
0,03 g № 5, № 10 | G04CX |
 Prostatilen Solution for injections Active ingredient
|
2 ml № 5, № 10 | G04СX |
 Prostatilen-Zinc Rectal suppositories Active ingredient
|
№ 5, № 10 | G04CX |
 Santekvin Vaginal suppositories Active ingredient
|
0,15 g № 3 | G01AF05 |
Hormone drugs for systemic use
| Name | Dosage form | ATC code |
|---|---|---|
 Betamethasone Solution for injections Active ingredient
Group of action Hormone drugs for systemic use |
4 mg/ml, 1 ml № 5, № 10, № 100 | Н02АВ01 |
 Dexamethasone Solution for injections Active ingredient
Group of action Hormone drugs for systemic use |
4 mg/ml, 1 ml № 5 | H02AB02 |
|
|
4 mg/1 ml № 5, № 100 | H02AB02 |
Antimicrobial agents for systemic use
| Name | Dosage form | ATC code |
|---|---|---|
 Aciclovir Tablets Active ingredient
Group of action Antimicrobial agents for systemic use |
0,2 g № 10, № 20 | J05AB01 |
 Amicacin sulfate Solution for injections Active ingredient
Group of action Antimicrobial agents for systemic use |
50 mg/ml, 2 ml № 1 | J01GB06 |
 Amikacin sulfate Solution for injections Active ingredient
Group of action Antimicrobial agents for systemic use |
250 mg/ml, 2 ml № 1 | J01GB06 |
 Cefazolin Powder for solution for injections Active ingredient
Group of action Antimicrobial agents for systemic use |
1,0 g № 1, № 5, № 50 | J01DB04 |
 Cefepime Powder for solution for injections Active ingredient
Group of action Antimicrobial agents for systemic use |
1 g № 1, № 5, № 50 | J01DE01 |
 Cefotaxime Powder for solution for injections Active ingredient
Group of action Antimicrobial agents for systemic use |
1.0 g № 1, № 5, № 50 | J01DD01 |
 Cefotaxime + Water for injection Powder for solution for injections Active ingredient
Group of action Antimicrobial agents for systemic use |
1 vial and 1 ampoule | J01D D01 |
 Ceftazidime Powder for solution for injections Active ingredient
Group of action Antimicrobial agents for systemic use |
1,0 g № 1, № 5, № 50 | J01DD02 |
 Ceftriaxone Solution for injections Active ingredient
Group of action Antimicrobial agents for systemic use |
1,0 g № 1, № 5, № 50 | J01DD04 |
 Ceftriaxone + Lidocaine Powder for solution for injections Active ingredient
Group of action Antimicrobial agents for systemic use |
1 vial and 1 ampoule | J01D D04 |
 Ceftriaxone + Water for injection Powder for solution for injections Active ingredient
Group of action Antimicrobial agents for systemic use |
1 vial and 1 ampoule | J01D D04 |
 Cefuroxime Powder for solution for injections Active ingredient
Group of action Antimicrobial agents for systemic use |
0,75 g, 1,5 g № 1, № 5, № 50 | J01DС02 |
 Cefuroxime + Water for injection Powder for solution for injections Active ingredient
Group of action Antimicrobial agents for systemic use |
1 vial and 1 ampoule | J01D С02 |
 Ciprofloxacin Film-coated tablets Active ingredient
Group of action Antimicrobial agents for systemic use |
500 mg № 10 | J01MA02 |
 Ciprofloxacin Film-coated tablets Active ingredient
Group of action Antimicrobial agents for systemic use |
250 mg № 10 | J01MA02 |
 Cycloserine Hard capsules Active ingredient
Group of action Antimicrobial agents for systemic use |
250 mg № 60 | J04AВ01 |
 Fluconazole Film-coated tablets Active ingredient
Group of action Antimicrobial agents for systemic use |
50 mg № 10 | J02AC02 |
 Fluconazole Film-coated tablets Active ingredient
Group of action Antimicrobial agents for systemic use |
100 mg № 10 | J02AC01 |
 Fluconazole Film-coated tablets Active ingredient
Group of action Antimicrobial agents for systemic use |
150 mg № 1, № 2 | J02AC01 |
  Imipenem/Cilastatin Powder for solution for infusion Active ingredient
Group of action Antimicrobial agents for systemic use |
500 mg/500 mg № 1, № 10, № 50 | J01DH51 |
 Lamivudine Film-coated tablets Active ingredient
Group of action Antimicrobial agents for systemic use |
150 mg № 60 | J05AF05 |
 Lazivudine Film-coated tablets Active ingredient
Group of action Antimicrobial agents for systemic use |
№ 60 | J05AR01 |
|
|
1,0 g № 1, № 5, № 50 | J01DD04 |
 Lekcef + Water for injections Active ingredient
Group of action Antimicrobial agents for systemic use |
1 vial and 1 ampoule | J01DD04 |
|
|
1,0 g № 1 | J01DB04 |
|
|
1.0 g № 1 | J01DD01 |
 Lektaxime + Water for injection Active ingredient
Group of action Antimicrobial agents for systemic use |
1 vial and 1 ampoule | J01DD01 |
 Levofloxacin Film-coated tablets Active ingredient
Group of action Antimicrobial agents for systemic use |
250 mg № 10 | J01MA12 |
 Levofloxacin Film-coated tablets Active ingredient
Group of action Antimicrobial agents for systemic use |
500 mg № 10 | J01MA12 |
 Meropenem Powder for solution for injections Active ingredient
Group of action Antimicrobial agents for systemic use |
0,5 g № 1 | J01DH02 |
 Meropenem Powder for solution for injections Active ingredient
Group of action Antimicrobial agents for systemic use |
1,0 g № 1 | J01DH02 |
 Moxifloxacin Film-coated tablets Active ingredient
Group of action Antimicrobial agents for systemic use |
400 mg № 5, № 7, № 10 | J01MA14 |
 Nitroxoline Film-coated tablets Active ingredient
Group of action Antimicrobial agents for systemic use |
50 mg № 10, № 50 | J01XX07 |
|
|
0,2 g № 10 | J01MA01 |
 PAS-ISO Enterosoluble granules Active ingredient
Group of action Antimicrobial agents for systemic use |
100 g granules in bag № 1 | J04AM |
 Promocef Powder for solution for injections Active ingredient
Group of action Antimicrobial agents for systemic use |
1,0 g № 1, № 5 | J01DD04 |
 Protech Film-coated tablets Active ingredient
Group of action Antimicrobial agents for systemic use |
250 mg № 50, № 500 | J04AD01 |
 Sodium aminosalicylate Enterosoluble granules Group of action Antimicrobial agents for systemic use |
0,8 g/1g, 100 g № 1 | J04AA02 |
 Terizidon Hard capsules Active ingredient
Group of action Antimicrobial agents for systemic use |
250 mg № 10 | J04AK03 |
 Triseptol Tablets Active ingredient
Group of action Antimicrobial agents for systemic use |
100 mg/20 mg № 20 | J01EE01 |
 Triseptol Tablets Active ingredient
Group of action Antimicrobial agents for systemic use |
400 mg/80 mg № 20 | J01EE01 |
 Urosept Suppositories Active ingredient
Group of action Antimicrobial agents for systemic use |
0,2 g № 10 | J01MB04 |
 Zidovudine Oral solution Active ingredient
Group of action Antimicrobial agents for systemic use |
10 mg/ml 200 ml | J05AF01 |
| Name | Dosage form | ATC code |
|---|---|---|
 Irinotecan Concentrate for solution for infusion Active ingredient
Group of actionAntineoplastic and immunomodulating agents |
20 mg/ml, 2 ml № 1 | L01XX19 |
 Oxaliplatin Lyophilisate solution for infusion Active ingredient
Group of actionAntineoplastic and immunomodulating agents |
50 mg, 100 mg № 1 | L01XА03 |
Agents affecting musculo-skeletal system
| Name | Dosage form | ATC code |
|---|---|---|
 Desket Solution for injections Active ingredient
Group of action Agents affecting musculo-skeletal system |
25 mg/ml, 2 ml № 10 | M01AE17 |
 Diclofenac Rectal suppositories Active ingredient
Group of action Agents affecting musculo-skeletal system |
0,1 g № 10 | M01AB05 |
 Diclofenac Solution for injections Active ingredient
Group of action Agents affecting musculo-skeletal system |
25 mg/ml, 3 ml №5 | M01AB05 |
 Ibuprofen Film-coated tablets Active ingredient
Group of action Agents affecting musculo-skeletal system |
200 mg № 10, № 50 | M01AE01 |
 Inflamine Rectal suppositories Active ingredient
Group of action Agents affecting musculo-skeletal system |
0,015 g № 10 | M01AC06 |
 Inflamine Solution for injections Active ingredient
Group of action Agents affecting musculo-skeletal system |
15 mg/1,5 ml in ampoule № 5 | М01АС06 |
 Ketalgin Tablets Active ingredient
Group of action Agents affecting musculo-skeletal system |
0,01 g, № 10 | M01AB15 |
 Ketalgin Long Solution for injections Active ingredient
Group of action Agents affecting musculo-skeletal system |
30 mg/ml 1 ml № 10 | M01AB15 |
|
|
100 mg № 10 | M01AB05 |
 Lekfenac Active ingredient
Group of action Agents affecting musculo-skeletal system |
75 mg/3 ml № 5, № 100 | М01АВ05 |
 Lektalgin Active ingredient
Group of action Agents affecting musculo-skeletal system |
30 mg/ml 1 ml № 10, № 100 | M01AB15 |
 Meloxicam Tablets Active ingredient
Group of action Agents affecting musculo-skeletal system |
0,0075 g № 10 ,№ 20 | M01AC06 |
 Meloxicam Tablets Active ingredient
Group of action Agents affecting musculo-skeletal system |
0,015 g № 10, № 20 | M01AC06 |
 Nimesulide Tablets Active ingredient
Group of action Agents affecting musculo-skeletal system |
0,1 g № 10, № 30 | M01AX17 |
 Ortophen Enterosoluble tablets Active ingredient
Group of action Agents affecting musculo-skeletal system |
25 mg № 10, № 30 | M01AB05 |
 Piroxicam Suppositories Active ingredient
Group of action Agents affecting musculo-skeletal system |
0,02 g № 10 | M01AC01 |
 Zoledronic acid Concentrate for solution for infusion Active ingredient
Group of action Agents affecting musculo-skeletal system |
0,8 mg/ml, 5 ml № 1, № 5, № 10 | М05ВА08 |
Agents affecting the nervous system
| Name | Dosage form | ATC code |
|---|---|---|
 Acetylsalicylic acid Tablets Active ingredient
Group of action Agents affecting the nervous system |
500 mg № 10 | N02BA01 |
 Alzhmerat Solution for injections Active ingredient
Group of action Agents affecting the nervous system |
250 mg/ml, 4 ml № 5, № 10, № 100 | N07AX02 |
 Amitriptyline Film-coated tablets Active ingredient
Group of action Agents affecting the nervous system |
25 mg № 50, № 1000 | N06AA09 |
 Analgin Solution for injections Active ingredient
Group of action Agents affecting the nervous system |
500 mg/ml, 2 ml № 10 | N02BB02 |
 Analgin for children Rectal suppositories Active ingredient
Group of action Agents affecting the nervous system |
0,1 g № 10 | N02BB02 |
 Analgin for children Rectal suppositories Active ingredient
Group of action Agents affecting the nervous system |
0,25 g № 10 | N02BB02 |
 Azaleptol Tablets Active ingredient
Group of action Agents affecting the nervous system |
25 mg, 100 mg № 50 | N05AH02 |
 Barwiton Solution for injections Active ingredient
Group of action Agents affecting the nervous system |
5 mg/ml, 2 ml № 10 | N06BX18 |
|
|
0,25 g № 10 | N05CM11 |
 Carbamazepine Tablets Active ingredient
Group of action Agents affecting the nervous system |
200 mg № 20, № 50 | N03AF01 |
 Cinnarizine Tablets Active ingredient
Group of action Agents affecting the nervous system |
0,025 g № 25, № 50 | N07CA02 |
 Citicoline Solution for injections Active ingredient
Group of action Agents affecting the nervous system |
125 mg/ml, 4 ml № 5, № 10, № 100 | N06ВХ06 |
 Citicoline Solution for injections Active ingredient
Group of action Agents affecting the nervous system |
250 mg/ml, 4 ml № 5, № 10, № 100 | N06BX06 |
 Gabapentin Hard capsules Active ingredient
Group of action Agents affecting the nervous system |
300 mg № 20 | N03AX12 |
 Lidocaine Solution for injections Active ingredient
Group of action Agents affecting the nervous system |
20 mg/ml, 2 ml in ampoules № 10 | N01BB02 |
 Lidocaine Solution for injections Active ingredient
Group of action Agents affecting the nervous system |
10 mg/ml, 3,5 ml № 10 | N01BВ02 |
|
|
№ 20 | N05CM |
 Novocaine Solution for injections Active ingredient
Group of action Agents affecting the nervous system |
5 mg/ml, 5 ml № 10 | N01BA02 |
 Piracetam Solution for injections Active ingredient
Group of action Agents affecting the nervous system |
200 mg/mg, 5 ml № 10 | N06BX03 |
  Tet 36.6 RAPID with acacia flavour Powder for oral solution Group of action Agents affecting the nervous system |
23 g № 5, № 10 | N02BЕ51 |
 Tet 36.6 RAPID with lemon flavour Powder for oral solution Group of action Agents affecting the nervous system |
23 g № 5, № 10 | N02BЕ51 |
 Tеt 36.6 MAXI with lemon flavour Powder for oral solution Group of action Agents affecting the nervous system |
23 g № 5, № 10 | N02BЕ51 |
 Tеt 36.6 MAXI with raspberry flavour Powder for oral solution Group of action Agents affecting the nervous system |
23 g № 5, № 10 | N02BE51 |
 Tеt 36.6 with acacia flavour Powder for oral solution Active ingredient
Group of action Agents affecting the nervous system |
13,1 g № 5, № 10 | N02BE51 |
 Tеt 36.6 with lemon flavour Powder for oral solution Active ingredient
Group of action Agents affecting the nervous system |
13,1 g № 5, № 10 | N02BE51 |
|
|
75 mg № 30 | N06AX16 |
 Venocor Solution for injections Active ingredient
Group of action Agents affecting the nervous system |
50 mg/ml 2 ml № 10 | N07XX |
 Venocor Solution for injections Active ingredient
Group of action Agents affecting the nervous system |
50 mg/ml, 5 ml № 5 | N07XX |
 Vinpocetin Tablets Active ingredient
Group of action Agents affecting the nervous system |
0,005 g № 30, № 50 | N06BX18 |
Anti-parasite agents, insecticides and repellents
| Name | Dosage form | ATC code |
|---|---|---|
 PerMin Solution for external administration Active ingredient
Group of action Anti-parasite agents, insecticides and repellents |
50 g | - |
 PerMin NEW Solution for external administration Active ingredient
Group of action Anti-parasite agents, insecticides and repellents |
50 ml | - |
Agents affecting the respiratory system
| Name | Dosage form | ATC code |
|---|---|---|
 Alergolik Film-coated tablets Active ingredient
Group of action Agents affecting the respiratory system |
5 mg № 10, № 30 | R06AE09 |
 Alergolik Oral drops Active ingredient
Group of action Agents affecting the respiratory system |
5 mg/ml, 10 ml № 1 | R06AE09 |
 Ambroxol Tablets Active ingredient
Group of action Agents affecting the respiratory system |
0,03 g № 10, № 20, № 50, № 100 | R05CB06 |
 Desloratadine Syrup Active ingredient
Group of action Agents affecting the respiratory system |
0,5 mg/ml, 60 ml № 1 | R06AX27 |
 Desloratadine Film-coated tablets Active ingredient
Group of action Agents affecting the respiratory system |
5 mg № 10, № 30 | R06AX27 |
 Ketotifen Tablets Active ingredient
Group of action Agents affecting the respiratory system |
0,001 g № 10, № 30 | R06AX17 |
 Loratadine Tablets Active ingredient
Group of action Agents affecting the respiratory system |
0,01 g № 10, № 20 | R06AX13 |
 |
50 ml № 1 | R02AA20 |
 Lorolik Solution for oral cavity Active ingredient
Group of action Agents affecting the respiratory system |
125 ml № 1 | R02AA20 |
|
|
2%, 125 ml | R05CB03 |
|
|
5%, 125 ml | R05СВ03 |
 Mucosol Solution for infusions Active ingredient
Group of action Agents affecting the respiratory system |
7,5 mg/ml № 10 | R05C B06 |
 Suprostilin Tablets Active ingredient
Group of action Agents affecting the respiratory system |
0,025 g № 10, № 20 | R06AC03 |
Miscellaneous agents
| Name | Dosage form | ATC code |
|---|---|---|
 Calcium folinate Solution for injections Active ingredient
Group of action Miscellaneous agents |
10 mg/ml, 3 ml or 5 ml № 5 | V03AF03 |
 Water for injections Solvent for parenteral administration Active ingredient
Group of action Miscellaneous agents |
2 ml № 10 | V07AB |
 Water for injections Solvent for parenteral administration Active ingredient
Group of action Miscellaneous agents |
5 ml № 10 | V07AB |
| Name | Dosage form | ATC code |
|---|---|---|
 AllSept Solution for external administration Active ingredient
Group of actionHealthcare Products
|
500 ml, 1000 ml, 5000 ml | |
 AllSept 75 Solution for external administration Active ingredient
Group of actionHealthcare Products
|
50 ml, 1000 ml, 5000 ml | |
|
|
№ 5, № 10 | - |
|
|
№ 5, № 10 | - |
|
|
100 ml | - |
|
|
№ 5, № 10 | - |
|
|
1,4 гg 2,4 g № 5, № 10 | |
|
|
50 tablets, 0,1 g | - |
|
|
with raspberry taste | - |
|
|
with mint taste | - |
|
|
with forest berry taste | - |
|
|
with tangerine taste | - |
|
|
with no-sugar contains | - |
